An update on topical photodynamic therapy for clinical dermatologists

References

• Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B Biol. 1990;6:143–148.
   PubMed Web of Science ®Google Scholar
• Sotiriou E, Evangelou G, Papadavid E, et al. Conventional vs. daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12-month follow-up results of a randomized, intra-individual comparative analysis. J Eur Acad Dermatol Venereol. 2018;32:595–600.
   PubMed Web of Science ®Google Scholar
• Fargnoli MC, Ibbotson SH, Hunger RE, et al. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries. J Eur Acad Dermatol Venereol. 2018;32:757–762.
   PubMed Web of Science ®Google Scholar
• Pei S, Kaminska ECN, Tsoukas MM. Treatment of actinic keratoses: a randomized split-site approach comparison of sequential 5-fluorouracil and 5-aminolevulinic acid photodynamic therapy to 5-aminolevulinic acid photodynamic monotherapy. Dermatol Surg. 2017;43:1170–1175.
   PubMed Web of Science ®Google Scholar
• Auriemma M, Di Nicola M, Gonzalez S, et al. Polypodium leucotomos supplementation in the treatment of scalp actinic keratosis: could it improve the efficacy of photodynamic therapy? Dermatol Surg. 2015;41:898–902.
   PubMed Web of Science ®Google Scholar
• Kohl E, Popp C, Zeman F, et al. Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo-controlled study. Br J Dermatol. 2017;176:352–362.
   PubMed Web of Science ®Google Scholar
• Petukhova TA, Hassoun LA, Foolad N, et al. Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses. JAMA Dermatol. 2017;153:637–643.
   PubMed Web of Science ®Google Scholar
• Vrani F, Sotiriou E, Lazaridou E, et al. Short incubation fractional CO2 laser-assisted photodynamic therapy vs. conventional photodynamic therapy in field-cancerized skin: 12-month follow-up results of a randomized intraindividual comparison study. J Eur Acad Dermatol Venereol. 2019;33:79–83.
   PubMed Web of Science ®Google Scholar
• Spencer JM, Freeman SA. Microneedling prior to levulan PDT for the treatment of actinic keratoses: a split-face, blinded trial. J Drugs Dermatol. 2016;15:1072–1074.
   PubMed Web of Science ®Google Scholar
• Zaar O, Fougelberg J, Hermansson A, et al. Effectiveness of photodynamic therapy in Bowen’s disease: a retrospective observational study in 423 lesions. J Eur Acad Dermatol Venereol. 2017;31:1289–1294.
   PubMed Web of Science ®Google Scholar
• Varma S, Wilson H, Kurwa HA, et al. Bowen’s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144:567–574.
   PubMed Web of Science ®Google Scholar
• Cai H, Wang YX, Zheng JC, et al. Photodynamic therapy in combination with CO2 laser for the treatment of Bowen’s disease. Lasers Med Sci. 2015;30:1505–1510.
   PubMed Web of Science ®Google Scholar
• Lu YG, Wang YY, Yang YD, et al. Efficacy of topical ALA-PDT combined with excision in the treatment of skin malignant tumor. Photodiagnosis Photodyn Ther. 2014;11:122–126.
   PubMed Web of Science ®Google Scholar
• Ko DY, Kim KH, Song KH. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. Br J Dermatol. 2014;170:165–172.
   PubMed Web of Science ®Google Scholar
• Samy NA, Salah MM, Ali MF, et al. Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma. Lasers Med Sci. 2015;30:109–115.
   PubMed Web of Science ®Google Scholar
• Haak CS, Togsverd-Bo K, Thaysen-Petersen D, et al. Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas-a randomized clinical trial. Br J Dermatol. 2015;172:215–222.
   PubMed Web of Science ®Google Scholar
• Ramirez DP, Kurachi C, Inada NM, et al. Experience and BCC subtypes as determinants of MAL-PDT response: preliminary results of a national Brazilian project. Photodiagnosis Photodyn Ther. 2014;11:22–26.
   PubMed Web of Science ®Google Scholar
• Zou Y, Zhao Y, Yu J, et al. Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis. J Cosmet Dermatol. 2016;15:374–382.
   PubMed Web of Science ®Google Scholar
• Wang H, Xu Y, Shi J, et al. Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed. 2015;31:44–53.
   PubMed Web of Science ®Google Scholar
• Roozeboom MH, Arits AHMM, Mosterd K, et al. Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial. J Invest Dermatol. 2016;136:1568–1574.
   PubMed Web of Science ®Google Scholar
• Dragieva G, Hafner J, Dummer R, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients. Transplantation. 2004;77:115–121.
   PubMedGoogle Scholar
• Joly F, Deret S, Gamboa B, et al. Photodynamic therapy corrects abnormal cancer-associated gene expression observed in actinic keratosis lesions and induces a remodeling effect in photodamaged skin. J Dermatol Sci. 2018;19:206–218.
   Google Scholar
• Schleier P, Hyckel P, Berndt A, et al. Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients. J Cancer Res Clin Oncol. 2004;130:279–284.
   PubMed Web of Science ®Google Scholar
• Piaserico S, Belloni Fortina A, Rigotti P, et al. Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplant Proc. 2007;39:1847–1850.
   PubMed Web of Science ®Google Scholar
• Heppt MV, Steeb T, Niesert AC. et al. Local interventions for actinic keratosis in organ transplant recipients: a systematic review. Br J Dermatol. 2018;180:43–50.
   PubMed Web of Science ®Google Scholar
• Guleng GE, Helsing P. Photodynamic therapy for basal cell carcinomas in organ-transplant recipients. Clin Exp Dermatol. 2012;37:367–369.
   PubMed Web of Science ®Google Scholar
• Togsverd-Bo K, Lei U, Erlendsson AM, et al. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial. Br J Dermatol. 2015;172:467–474.
   PubMed Web of Science ®Google Scholar
• de Graaf YG, Kennedy C, Wolterbeek R, et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol. 2006;126:569–574.
   PubMed Web of Science ®Google Scholar
• Willey A, Mehta S, Lee PK, et al. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg. 2010;36:652–658.
   PubMed Web of Science ®Google Scholar
• Togsverd-Bo K, Omland SH, Wulf HC, et al. Primary prevention of skin dysplasia in renal transplant recipients with photodynamic therapy: a randomized controlled trial. Am J Transplant. 2015;15:2986–2990.
   PubMedGoogle Scholar
• Jambusaria-Pahlajani A, Ortman S, Schmults CD, et al. Sequential curettage, 5-fluorouracil, and photodynamic therapy for field cancerization of the scalp and face in solid organ transplant recipients. Dermatol Surg. 2016;42:S66–S72.
   PubMed Web of Science ®Google Scholar
• Braathen LR, Morton CA, Basset-Seguin N, et al. Photodynamic therapy for skin field cancerization: an international consensus. International society for photodynamic therapy in dermatology. J Eur Acad Dermatol Venereol. 2012;26:1063–1066.
   PubMed Web of Science ®Google Scholar
• Apalla Z, Sotiriou E, Chovarda E, et al. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study. Br J Dermatol. 2010;162:171–175.
   PubMed Web of Science ®Google Scholar
• Sotiriou E, Apalla Z, Vrani F, et al. Daylight photodynamic therapy vs. Conventional photodynamic therapy as skin cancer preventive treatment in patients with face and scalp cancerization: an intra-individual comparison study. J Eur Acad Dermatol Venereol. 2017;31:1303–1307.
   PubMed Web of Science ®Google Scholar
• Szeimies RM, Torezan L, Niwa A, et al. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol. 2012;167:150–159.
   PubMed Web of Science ®Google Scholar
• Miola AC, Ferreira ER, Lima TRR, et al. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial. Br J Dermatol. 2018;179:1081–1087.
   PubMed Web of Science ®Google Scholar
• Gad F, Viau G, Bousbira M, et al. Photodynamic therapy with 5-aminolevulinic acid induces apoptosis and caspase activation in malignant T cells. J Cutan Med Surg. 2001;5:8–13.
   PubMed Web of Science ®Google Scholar
• Quereux G, Brocard A, Saint-Jean M, et al. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature. J Am Acad Dermatol. 2013;69:890–897.
   PubMed Web of Science ®Google Scholar
• Edstrom DW, Porwit A, Ros AM. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. Acta Derm Venereol. 2001;81:184–188.
   PubMed Web of Science ®Google Scholar
• Han D, Xue J, Wang T, et al. Observation of clinical efficacy of photodynamic therapy in 3 patients with refractory plaque-stage mycosis fungoides. Photodiagnosis Photodyn Ther. 2016;16:9–11.
   PubMed Web of Science ®Google Scholar
• Kim ST, Kang DY, Kang JS, et al. Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides. Acta Derm Venereol. 2012;92:264–268.
   PubMed Web of Science ®Google Scholar
• Kaufmann F, Kettelhack N, Hilty N, et al. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature. J Eur Acad Dermatol Venereol. 2017;31:1633–1637.
   PubMed Web of Science ®Google Scholar
• Pileri A, Sgubbi P, Agostinelli C, et al. Photodynamic therapy: an option in mycosis fungoides. Photodiagnosis Photodyn Ther. 2017;20:107–110.
   PubMed Web of Science ®Google Scholar
• Berking C, Herzinger T, Flaig MJ, et al. The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients. Dermatol Surg. 2007;33:825–830.
   PubMed Web of Science ®Google Scholar
• Fai D, Romano I, Cassano N, et al. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic cheilitis: a retrospective evaluation of 29 patients. G Ital Dermatol Venereol. 2012;147:99–101.
   PubMed Web of Science ®Google Scholar
• Sotiriou E, Apalla Z, Chovarda E, et al. Photodynamic therapy with 5-aminolevulinic acid in actinic cheilitis: an 18-month clinical and histological follow-up. J Eur Acad Dermatol Venereol. 2009;24:916–920.
   PubMed Web of Science ®Google Scholar
• Chaves YN, Torezan LA, Lourenco SV, et al. Evaluation of the efficacy of photodynamic therapy for the treatment of actinic cheilitis. Photodermatol Photoimmunol Photomed. 2017;33:14–21.
   PubMed Web of Science ®Google Scholar
• Sotiriou E, Lallas A, Goussi C, et al. Sequential use of photodynamic therapy and imiquimod 5% cream for the treatment of actinic cheilitis: a 12-month follow-up study. Br J Dermatol. 2011;165:888–892.
   PubMed Web of Science ®Google Scholar
• Levi A, Hodak E, Enk CD, et al. Daylight photodynamic therapy for the treatment of actinic cheilitis. Photodermatol Photoimmunol Photomed. 2018;35:11–16.
   PubMed Web of Science ®Google Scholar
• Fai D, Romanello E, Brumana MB, et al. Daylight photodynamic therapy with methyl-aminolevulinate for the treatment of actinic cheilitis. Dermatol Ther. 2015;28:355–368.
   PubMed Web of Science ®Google Scholar
• Radakovic S, Tanew A. 5-aminolaevulinic acid patch-photodynamic therapy in the treatment of actinic cheilitis. Photodermatol Photoimmunol Photomed. 2017;33:306–310.
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim KH, Song KH. Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial. Br J Dermatol. 2015;173:184–191.
   PubMed Web of Science ®Google Scholar
• Ma L, Xiang LH, Yu B, et al. Low-dose topical 5-aminolevulinic acid photodynamic therapy in the treatment of different severity of acne vulgaris. Photodiagnosis Photodyn Ther. 2013;10:583–590.
   PubMed Web of Science ®Google Scholar
• Pariser DM, Eichenfield LF, Bukhalo M, et al. Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study. Br J Dermatol. 2016;174:770–777.
   PubMed Web of Science ®Google Scholar
• Xu X, Zheng Y, Zhao Z, et al. Efficacy of photodynamic therapy combined with minocycline for treatment of moderate to severe facial acne vulgaris and influence on quality of life. Medicine (Baltimore). 2017;96:e9366.
   PubMed Web of Science ®Google Scholar
• Tao SQ, Li F, Cao L, et al. Low-dose topical 5-aminolevulinic acid photodynamic therapy in the treatment of different severity of acne vulgaris. Cell Biochem Biophys. 2015;73:701–706.
   PubMed Web of Science ®Google Scholar
• Liu LH, Fan X, An YX, et al. Randomized trial of three phototherapy methods for the treatment of acne vulgaris in Chinese patients. Photodermatol Photoimmunol Photomed. 2014;30:246–253.
   PubMed Web of Science ®Google Scholar
• Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol. 2018;178:61–75.
   PubMed Web of Science ®Google Scholar
• Yin R, Lin L, Xiao Y, et al. Combination ALA-PDT and ablative fractional Er:YAG laser (2,940 nm) on the treatment of severe acne. Lasers Surg Med. 2014;46:165–172.
   PubMed Web of Science ®Google Scholar
• Kwon HH, Moon KR, Park SY, et al. Daylight photodynamic therapy with 1.5% 3-butenyl 5-aminolevulinate gel as a convenient, effective and safe therapy in acne treatment: a double-blind randomized controlled trial. J Dermatol. 2016;43:515–521.
   PubMed Web of Science ®Google Scholar
• Kim SK, Koo GB, Kim YS, et al. Epithelial-mesenchymal interaction during photodynamic therapy-induced photorejuvenation. Arch Dermatol Res. 2016;308:493–501.
   PubMed Web of Science ®Google Scholar
• Issa MC, Pineiro-Maceira J, Vieira MT, et al. Photorejuvenation with topical methyl aminolevulinate and red light: a randomized, prospective, clinical, histopathologic, and morphometric study. Dermatol Surg. 2010;36:39–48.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Ji J, Tan YM, et al. Evaluation of 5-aminolevulinic acid-mediated photorejuvenation of neck skin. Photodiagnosis Photodyn Ther. 2014;11:498–509.
   PubMed Web of Science ®Google Scholar
• Kosaka S, Yasumoto M, Akilov OE, et al. Comparative split-face study of 5-aminolevulinic acid photodynamic therapy with intense pulsed light for photorejuvenation of Asian skin. J Dermatol. 2010;37:1005–1010.
   PubMed Web of Science ®Google Scholar
• Haddad A, Santos ID, Gragnani A, et al. The effect of increasing fluence on the treatment of actinic keratosis and photodamage by photodynamic therapy with 5-aminolevulinic acid and intense pulsed light. Photomed Laser Surg. 2011;29:427–432.
   PubMed Web of Science ®Google Scholar
• Palm MD. Goldman MP. Safety and efficacy comparison of blue versus red light sources for photodynamic therapy using methyl aminolevulinate in photodamaged skin. J Drugs Dermatol. 2011;10:53–60.
   PubMed Web of Science ®Google Scholar
• Clementoni MT, B-Roscher M, Munavalli GS. Photodynamic photorejuvenation of the face with a combination of microneedling, red light, and broadband pulsed light. Lasers Surg Med. 2010;42:150–159.
   PubMed Web of Science ®Google Scholar
• Lu YG, Wu JJ, He Y, et al. Efficacy of topical aminolevulinic acid photodynamic therapy for the treatment of verruca planae. Photomed Laser Surg. 2010;28:561–563.
   PubMed Web of Science ®Google Scholar
• Li Q, Jiao B, Zhou F, et al. Comparative study of photodynamic therapy with 5%, 10% and 20% aminolevulinic acid in the treatment of generalized recalcitrant facial verruca plana: a randomized clinical trial. J Eur Acad Dermatol Venereol. 2014;28:1821–1826.
   PubMed Web of Science ®Google Scholar
• Qian G, Wang S, Deng D, et al. Is the step-up therapy of topical 5-aminolevulinic acid photodynamic therapy effective and safe for the patients with recalcitrant facial flat wart? Dermatol Ther. 2014;27:83–88.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lu XN, Liang J, et al. Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminate. Int J Clin Exp Med. 2015;8:6517–6521.
   PubMed Web of Science ®Google Scholar
• Shi H, Zhang X, Ma C, et al. Clinical analysis of five methods used to treat condylomata acuminata. Dermatology. 2013;227:338–345.
   PubMed Web of Science ®Google Scholar
• Yang YG, Zou XB, Zhao H, et al. Photodynamic therapy of condyloma acuminata in pregnant women. Chin Med J. 2012;125:2925–2928.
   PubMed Web of Science ®Google Scholar
• Xu M, Lin N, Li J, et al. Photodynamic therapy as an alternative therapeutic option for pediatric condyloma acuminata: a case series. Photodiagnosis Photodyn Ther. 2018;24:179–181.
   Web of Science ®Google Scholar
• Hu YE, Dai SF, Wang B, et al. Therapeutic effects of topical 5-aminolevulinic acid photodynamic therapy. Pak J Med Sci. 2016;32:961–964.
   PubMed Web of Science ®Google Scholar
• Lu YG, Yang YD, Wu JJ, et al. Treatment of perianal condyloma acuminate with topical ALA-PDT combined with curettage: outcome and safety. Photomed Laser Surg. 2012;30:186–190.
   PubMed Web of Science ®Google Scholar
• Wang HW, Zhang LL, Miao F, et al. Treatment of HPV infection-associated cervical condylomata acuminata with 5-aminolevulinic acid-mediated photodynamic therapy. Photochem Photobiol. 2012;88:565–569.
   PubMed Web of Science ®Google Scholar
• Hu Z, Liu L, Zhang W, et al. Dynamics of HPV viral loads reflect the treatment effect of photodynamic therapy in genital warts. Photodiagnosis Photodyn Ther. 2018;21:86–90.
   PubMed Web of Science ®Google Scholar
• Andrade CG, Figueiredo R, Ribeiro KRC, et al. Photodynamic effect of zinc porphyrin on the promastigote and amastigote forms of Leishmania braziliensis. Photochem Photobiol Sci. 2018;17:482–490.
   PubMed Web of Science ®Google Scholar
• Ghaffarifar F, Jorjani O, Mirshams M, et al. Photodynamic therapy as a new treatment of cutaneous leishmaniasis. East Mediter Health J. 2006;12:902–908.
   PubMedGoogle Scholar
• Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of old world cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol. 2006;31:634–637.
   PubMed Web of Science ®Google Scholar
• Enk CD, Nasereddin A, Alper R, et al. Cutaneous leishmaniasis responds to daylight-activated photodynamic therapy: proof of concept for a novel self-administered therapeutic modality. Br J Dermatol. 2015;172:1364–1370.
   PubMed Web of Science ®Google Scholar
• Enk CD, Fritsch C, Jonas F, et al. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol. 2003;139:432–434.
   PubMedGoogle Scholar
• Peng J, Feng W, Luo X, et al. A clinical trial using attrition combined with 5-aminolevulinic acids based photodynamic therapy in treating squamous cell carcinoma. Med Sci Monit. 2017;23:1347–1354.
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim KH, Song KH. Effect of methyl aminolevulinate photodynamic therapy with and without ablative fractional laser treatment in patients with microinvasive squamous cell carcinoma: a randomized clinical trial. JAMA Dermatol. 2017;153:289–295.
   PubMed Web of Science ®Google Scholar
• Calista D. Development of squamous cell carcinoma after photodynamic therapy with methyl aminoleuvulinate. Br J Dermatol. 2014;171:905–908.
   PubMed Web of Science ®Google Scholar
• Gracia Cazana T, Salazar N, Vera-Alvarez J, et al. Comparative study of the clinical, histological, and biological characteristics of squamous cell carcinomas in areas previously treated with photodynamic therapy. Eur J Dermatol. 2017;27:627–634.
   PubMed Web of Science ®Google Scholar
• Raspagliesi F, Fontanelli R, Rossi G, et al. Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget’s disease of the vulva: a pilot study. Gynecol Oncol. 2006;103:581–586.
   PubMed Web of Science ®Google Scholar
• Rioli DI, Samimi M, Beneton N, et al. Efficacy and tolerance of photodynamic therapy for vulvar Paget’s disease: a multicentric retrospective study. Eur J Dermatol. 2018;28:351–355.
   PubMed Web of Science ®Google Scholar
• Fontanelli R, Papadia A, Martinelli F, et al. Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget’s disease. Gynecol Oncol. 2013;130:90–94.
   PubMed Web of Science ®Google Scholar
• Li Q, Gao T, Jiao B, et al. Long-term follow-up of in situ extramammary Paget’s disease in Asian skin types IV/V treated with photodynamic therapy. Acta Derm Venereol. 2010;90:159–164.
   PubMed Web of Science ®Google Scholar
• Shieh S, Dee AS, Cheney RT, et al. Photodynamic therapy for the treatment of extramammary Paget's disease. Br J Dermatol. 2002;146:1000–1005.
   PubMed Web of Science ®Google Scholar
• Wang HW, Lv T, Zhang LL, et al. A prospective pilot study to evaluate combined topical photodynamic therapy and surgery for extramammary Paget’s disease. Lasers Surg Med. 2013;45:296–301.
   PubMed Web of Science ®Google Scholar
• Zawislak AA, McCluggage WG, Donnelly RF, et al. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed. 2009;25:111–113.
   PubMed Web of Science ®Google Scholar
• Biniszkiewicz T, Olejek A, Kozak-Darmas I, et al. Therapeutic effects of 5-ALA-induced photodynamic therapy in vulvar lichen sclerosus. Photodiagnosis Photodyn Ther. 2005;2:157–160.
   PubMed Web of Science ®Google Scholar
• Mazdziarz A, Osuch B, Kowalska M, et al. Photodynamic therapy in the treatment of vulvar lichen sclerosus. Photodiagnosis Photodyn Ther. 2017;19:135–139.
   PubMed Web of Science ®Google Scholar
• Sotiriou E, Apalla Z, Patsatsi A, et al. Recalcitrant vulvar lichen sclerosis treated with aminolevulinic acid-photodynamic therapy: a report of five cases. J Eur Acad Dermatol Venereol. 2008;22:1398–1399.
   PubMed Web of Science ®Google Scholar
• Skrzypulec V, Olejek A, Drosdzol A, et al. Sexual functions and depressive symptoms after photodynamic therapy for vulvar lichen sclerosus in postmenopausal women from the upper Silesian region of Poland. J Sex Med. 2009;6:3395–3400.
   PubMed Web of Science ®Google Scholar
• Shi L, Miao F, Zhang LL, et al. Comparison of 5-aminolevulinic acid photodynamic therapy and clobetasol propionate in treatment of vulvar lichen sclerosus. Acta Derm Venerol. 2016;96:684–688.
   PubMed Web of Science ®Google Scholar
• Byun JY, Lee GY, Choi HY, et al. The expressions of TGF-β(1) and IL-10 in cultured fibroblasts after ALA-IPL photodynamic treatment. Ann Dermatol. 2011;23:19–22.
   PubMed Web of Science ®Google Scholar
• Collins P, Robinson D, Stringer M, et al. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1997;137:743–749.
   PubMed Web of Science ®Google Scholar
• Choi YM, Adelzadeh L, Wu JJ. Photodynamic therapy for psoriasis. J Dermatolog Treat. 2015;26:202–207.
   PubMed Web of Science ®Google Scholar
• Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol. 1999;79:451–455.
   PubMed Web of Science ®Google Scholar
• Calzavara-Pinton PG, Rossi MT, Aronson E, et al. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and Aesthetic Indications. Photochem Photobiol Sci. 2013;12:148–157.
   PubMed Web of Science ®Google Scholar
• Schleyer V, Radakovic-Fijan S, Karrer S, et al. Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolaevulinic acid in psoriasis. A randomized, double-blind phase I/II study. J Eur Acad Dermatol Venereol. 2006;20:823–828.
   PubMed Web of Science ®Google Scholar
• Warren CB, Karai LJ, Vidimos A, et al. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. J Am Acad Dermatol. 2009;61:1033–1043.
   PubMed Web of Science ®Google Scholar
• Radakovic‐Fijan S, Blecha TU, Schleyer V, et al. Topical aminolaevulinic acid‐based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer‐blinded study. Br J Dermatol. 2005;152:279–283.
   PubMed Web of Science ®Google Scholar
• Jiaravuthisan MM, Sasseville D, Vender RB, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57:1–27.
   PubMed Web of Science ®Google Scholar
• Clark C, Bryden A, Dawe R, et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photoderm Photoimm Photomed. 2003;19:134–141.
   PubMed Web of Science ®Google Scholar
• Waters AJ, Ibbotson SH. Parameters associated with severe pain during photodynamic therapy: results of a large Scottish series. Br J Dermatol. 2011;165:696–698.
   PubMed Web of Science ®Google Scholar
• Miller IM, Nielsen JS, Lophaven S, et al. Factors related to pain during routine photodynamic therapy: a descriptive study of 301 patients. J Eur Acad Dermatol Venereol. 2011;25:1275–1281.
   PubMed Web of Science ®Google Scholar
• Ibbotson SH. Adverse effects of topical photodynamic therapy. Photodermatol Photoimmunol Photomed. 2011;27:116–130.
   PubMed Web of Science ®Google Scholar
• Yazdanyar S, Zarchi K, Jemec GBE. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix ®) to aminolaevulinic acid (Ameluz®); an intra-individual clinical study. Photodiagnosis Photodyn Ther. 2017;20:6–9.
   PubMed Web of Science ®Google Scholar
• Wiegell SR, Petersen B, Wulf HC. Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial. Br J Dermatol. 2016;174:979–984.
   PubMed Web of Science ®Google Scholar
• Klein A, Karrer S, Horner C, et al. Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial. Br J Dermatol. 2015;173:192–200.
   PubMed Web of Science ®Google Scholar
• Vanaman Wilson MJ, Jones IT, Wu DC, et al. A randomized, double-blind, placebo-controlled clinical trial evaluating the role of systemic antihistamine therapy for the reduction of adverse effects associated with topical 5-aminolevulinic acid photodynamic therapy. Lasers Surg Med. 2017;49:738–742.
   PubMed Web of Science ®Google Scholar
• Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SorT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004;69:548–556.
   PubMed Web of Science ®Google Scholar
• Di Venosa G, Hermida L, Batlle A, et al. Characterisation of liposomes containing aminolevulinic acid and derived esters. J Photochem Photobiol B Biol. 2008;92:1–9.
   PubMed Web of Science ®Google Scholar
• Schmitz L, Novak B, Hoeh AK, et al. Epidermal penetration and protoporphyrin IX formation of two different 5-aminolevulinic acid formulations in ex vivo human skin. Photodiagnosis Photodyn Ther. 2016;14:40–46.
   PubMed Web of Science ®Google Scholar
• Rasanen JE, Neittaanmaki N, Ylitalo L, et al. 5-aminolevulinic acid nanoemulsion (BF-200 ALA) is more effective than methyl-5-aminolevulinate (MAL) in daylight photodynamic therapy for actinic keratosis: a non-sponsored randomized double-blind multicentre trial. Br J Dermatol. 2018. DOI:10.1111/bjd.17311
   PubMed Web of Science ®Google Scholar
• Dirschka T, Radny P, Dominicus R, et al. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol. 2013;168:825–836.
   PubMed Web of Science ®Google Scholar
• Gholam P, Weberschock T, Denk K, et al. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis. Dermatology. 2011;222:358–362.
   PubMed Web of Science ®Google Scholar
• McCarron PA, Donnelly RF, Zawislak A, et al. Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions. Eur J Pharm Sci. 2006;27:268–279.
   PubMed Web of Science ®Google Scholar
• Reinhold U, Petering H, Dirschka T, et al. Photodynamic therapy with a 5-ALA-patch does not increase the risk of conversion of actinic keratoses into squamous cell carcinoma. Exp Dermatol. 2018;27:1399–1402.
   PubMed Web of Science ®Google Scholar
• Park KY, Kim JY, Hyun MY, et al. 1,213 Cases of treatment of facial acne using indocyanine green and intense pulsed light in Asian skin. BioMed Res Int. 2015;2015:1.
   Google Scholar
• Fadel M, Samy N, Nasr M, et al. Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma. Pharm Dev Technol. 2017;22:545–550.
   PubMed Web of Science ®Google Scholar
• Na JI, Kim SY, Kim JH, et al. Indole-3-acetic acid: a potential new photosensitizer for photodynamic therapy of acne vulgaris. Lasers Surg Med. 2011;43:200–205.
   PubMed Web of Science ®Google Scholar
• Grandi V, Baldi I, Cappugi P, et al. Indole 3-acetic acid-photodynamic therapy in the treatment of multiple actinic keratoses: a proof of concept pilot study. Photodiagnosis Photodyn Ther. 2016;16:17–22.
   PubMed Web of Science ®Google Scholar
• Kacerovska D, Pizinger K, Majer F, et al. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract–a pilot study. Photochem Photobiol. 2008;84:779–785.
   PubMed Web of Science ®Google Scholar
• Rook AH, Wood GS, Duvic M, et al. A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. J Am Acad Dermatol. 2010;63:984–990.
   PubMed Web of Science ®Google Scholar
• Baron ED, Malbasa CL, Santo-Domingo D, et al. Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial. Lasers Surg Med. 2010;42:728–735.
   PubMed Web of Science ®Google Scholar
• Hutnick MA, Ahsanuddin S, Guan L, et al. PEGylated dendrimers as drug delivery vehicles for the photosensitizer silicon phthalocyanine Pc 4 for candidal infections. 2017;18:379–385.
   Google Scholar
• Lam M, Dimaano ML, Oyetakin-White P, et al. Silicon phthalocyanine 4 phototoxicity in Trichophyton rubrum. Antimicrob Agents Chemother. 2014;58:3029–3034.
   PubMed Web of Science ®Google Scholar
• Dimaano ML, Rozario C, Nerandzic MM, et al. The photodynamic antibacterial effects of silicon phthalocyanine (Pc) 4. Int J Mol Sci. 2015;16( 4):7851–7860.
   PubMed Web of Science ®Google Scholar
• Morley S, Griffiths J, Philips G, et al. Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy. Br J Dermatol. 2013;168:617–624.
   PubMed Web of Science ®Google Scholar
• Akilov OE, Yousaf W, Lukjan SX, et al. Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis. Lasers Surg Med. 2009;41:358–365.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Tu P, Zhou G, et al. Hemoporfin photodynamic therapy for port-wine stain: a randomized controlled trial. PLoS One. 2016;11:e0156219.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zou X, Chen H, et al. Clinical study on clinical operation and post-treatment reactions of HMME-PDT in treatment of PWS. Photodiagnosis Photodyn Ther. 2017;20:253–256.
   PubMed Web of Science ®Google Scholar
• Tang Y, Xie H, Li J, et al. The association between treatment reactions and treatment efficiency of Hemoporfin-photodynamic therapy on port wine stains: a prospective double blind randomized controlled trial. Photodiagnosis Photodyn Ther. 2017;18:171–178.
   PubMed Web of Science ®Google Scholar
• Cai H, Gu Y, Sun Q, et al. Effect of hematoporphyrin monomethyl ether-mediated photodynamic therapy on hypertrophic scar fibroblasts. Photodermatol Photoimmunol Photomed. 2011;27:90–96.
   PubMed Web of Science ®Google Scholar
• Mendoza-Garcia J, Sebastian A, Alonso-Rasgado T, et al. Ex vivo evaluation of the effect of photodynamic therapy on skin scars and striae distensae. Photodermatol Photoimmunol Photomed. 2015;31:239–251.
   PubMed Web of Science ®Google Scholar
• Mendoza J, Sebastian A, Allan E, et al. Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor, fluence and location of fibroblasts within the lesion. Arch Dermatol Res. 2012;304:549–562.
   PubMed Web of Science ®Google Scholar
• Ud-Din S, Thomas G, Morris J, et al. Photodynamic therapy: an innovative approach to the treatment of keloid disease evaluated using subjective and objective non-invasive tools. Arch Dermatol Res. 2013;305:205–214.
   PubMed Web of Science ®Google Scholar
• Sakamoto FH, Izikson L, Tannous Z, et al. Surgical scar remodelling after photodynamic therapy using aminolaevulinic acid or its methylester: a retrospective, blinded study of patients with field cancerization. Br J Dermatol. 2012;166:413–416.
   PubMed Web of Science ®Google Scholar
• Weisenseel P, Kuznetsov AV, Molin S, et al. Photodynamic therapy for granuloma annulare: more than a shot in the dark. Dermatology. 2008;217:329–332.
   PubMed Web of Science ®Google Scholar
• Sung N, Back S, Jung J, et al. Inactivation of multidrug resistant (MDR)- and extensively drug resistant (XDR)-mycobacterium tuberculosis by photodynamic therapy. Photodiagnosis Photodyn Ther. 2013;10:694–702.
   PubMed Web of Science ®Google Scholar
• Sun K, Yang H, Huang X, et al. ALA-PDT combined with antibiotics for the treatment of atypical mycobacterial skin infections: outcomes and safety. Photodiagnosis Photodyn Ther. 2017;19:274–277.
   PubMed Web of Science ®Google Scholar
• Kaae J, Philipsen PA, Wulf HC. Photodynamic therapy of necrobiosis lipoidica using methyl aminolevulinate: a retrospective follow-up study. Photodiagnosis Photodyn Ther. 2018;22:223–226.
   PubMed Web of Science ®Google Scholar
• Berking C, Hegyi J, Arenberger P, et al. Photodynamic therapy of necrobiosis lipoidica–a multicenter study of 18 patients. Dermatology. 2009;218:136–139.
   PubMed Web of Science ®Google Scholar
• Truchuelo T, Alcantara J, Fernandez-Guarino M, et al. Photodynamic therapy for necrobiosis lipoidica is an unpredictable option: three cases with different results. Int J Dermatol. 2013;52:1589–1590.
   PubMed Web of Science ®Google Scholar
• Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990;136:891–897.
   PubMed Web of Science ®Google Scholar
• Richey DF. Aminolevulinic acid photodynamic therapy for sebaceous gland hyperplasia. Dermatol Clin. 2007;25:59–65.
   PubMed Web of Science ®Google Scholar
• Gold MH, Bradshaw VL, Boring MM, et al. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol. 2004;3:S6–S9.
   PubMedGoogle Scholar
• Kim SK, Do JE, Kang HY, et al. Combination of topical 5-aminolevulinic acid-photodynamic therapy with carbon dioxide laser for sebaceous hyperplasia. J Am Acad Dermatol. 2007;56:523–524.
   PubMed Web of Science ®Google Scholar